ESTRELLA IMMUNOPHARMA, INC. Adjustments to Additional Paid in Capital, Other
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Adjustments to Additional Paid in Capital, Other of -$582.97 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-03-14
- ESTRELLA IMMUNOPHARMA, INC. adjustments to additional paid in capital, other for the quarter ending 2021-09-30 was -$582.97K.
- ESTRELLA IMMUNOPHARMA, INC. adjustments to additional paid in capital, other for fiscal 2021 was -$582.97K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2021-12-31 | -$582.97K 10-K · filed 2023-03-14 | |
| 2021-09-30 | -$582.97K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |